FDBusiness.com

New clinically proven Flowens™ opens the door to fresh men’s health opportunities

 Breaking News
  • Kerry Group Announces Two Further Strategic Acquisitions Kerry Group, the global taste, nutrition and consumer foods business, has announced that it has agreed to acquire Ariake USA, the North American Business of Ariake Japan Co, and Southeastern Mills North American coatings and seasonings business (SEM), both deals are subject to customary closing conditions. These acquisitions further enhance Kerry Group’s foundational technology portfolio, [...]...
  • DMK Group and FrieslandCampina Sign Manufacturing Agreement Royal FrieslandCampina and DMK Group have signed a contract manufacturing agreement for mozzarella and yellow cheese production. The agreement will become effective in 2019. FrieslandCampina will supply the milk of its member dairy farmers to DMK. DMK will provide the production facilities and expertise at Hoogeveen (Netherlands) and Georgsmarienhütte (Germany). For this purpose, DMK will [...]...
  • Barry Callebaut Completes Deal With Burton’s Biscuit Company in the UK After signing an agreement with Burton’s Biscuit Company, the UK’s second biggest biscuit manufacturer, for the long-term supply of over 12,000 tonnes of chocolate and compound per year on September 19, 2018, Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, has now successfully closed the transaction. The deal also entails Barry Callebaut [...]...
  • Carlsberg Group Increases Ownership of Super Bock Group in Portugal The Carlsberg Group has acquired 28.5% of the shares in Viacerm which is the controlling shareholder of Super Bock Group, holding 56% of the shares. The other 44% of the shares in Super Bock Group are owned by Carlsberg. Super Bock Group is the market leader in Portugal, holding a market share of 47% with a [...]...
  • UK Restaurant Numbers Fall 2% in a Year The number of restaurants in Britain slipped by 2.0% over the year to September 2018, the new edition of the Market Growth Monitor from CGA and AlixPartners reveals – equivalent to more than 10 closures a week. The exclusive research shows that Britain had a total of 26,892 restaurants at September. The net fall of 539 [...]...

New clinically proven Flowens™ opens the door to fresh men’s health opportunities

April 23
11:28 2014

Avignon, 24th April 2014 – Naturex has launched a natural, clinically proven botanical ingredient that addresses an uncomfortable prostate condition common among men – without causing any side effects.

Flowens™ is a full spectrum cranberry powder engineered to relieve the lower urinary tract symptoms typically associated with benign prostatic hyperplasia (BPH). It offers an effective and safe alternative to existing pharmaceutical remedies and other, less effective botanical options. BPH can cause an overactive bladder, leading to increased frequency of urination, or an underactive bladder, resulting in hesitancy, intermittency, weak stream and an inability to empty the bladder fully. The symptoms can impair quality of life.

Research suggests 26% of men in their 40s display lower urinary tract symptoms that are moderate to severe, with this figure rising to 33% for men in their 60s, 41% for men in their 70s, and 50% for men in their 80s. The numbers of men affected illustrates the significant market potential for an effective ingredient that helps alleviate BPH without any side effects – such as Flowens™.

Flowens™, which has been developed by Naturex for use in nutritional supplements and functional foods, is proven to ease the lower urinary tract symptoms typically associated with BPH. In a recent gold-standard clinical trial, patients with lower urinary tract symptoms who took Flowens™ experienced strong improvements in the key prostrate health marker – the International Prostrate Symptom Score (IPSS) – compared with a placebo.

Improvements in the IPSS were more marked as the intake was increased, with a 250mg daily dose of Flowens™ providing a 25% improvement and a 500mg daily dose offering a 44% improvement.

Dan Souza, Senior Director of Sales & Marketing at Naturex, said: “This trial demonstrates that Flowens™ is highly effective in alleviating the lower urinary tract symptoms typically associated with BPH, a condition that troubles millions of men across Europe. With so many sufferers, the market potential is enormous. Flowens™ is not only effective, but it is also free of the side effects associated with most pharmaceuticals in this space.”

Flowens™ will make its European debut at Vitafoods Europe, which takes place in Geneva from 6 to 8 May 2014. Naturex will exhibit on Stand 18033. Dan Souza is also scheduled to speak about the new ingredient at a seminar in the exhibition’s presentation theatre on 6 May 2013, from 3.10pm-3.40pm.

 

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 18, 2019Multimodal 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements